Avertto Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Early Stage VC
- (Cancelled)
- Investors
-
3
Avertto General Information
Description
Developer of a telemonitoring medical device designed to focus on AI and signal analysis to detect changes in the carotid pulse waves. The company's device offers AI-powered alerts and utilizes proprietary algorithms with an app for sending alerts, signal quality, deep learning, and false alerts, enabling healthcare providers to monitor, detect, and provide timely alerts regarding blood flow and physiological changes.
Contact Information
Website
www.avertto.comCorporate Office
- Aderet 1037
- Aderet
- Israel
Corporate Office
- Aderet 1037
- Aderet
- Israel
Avertto Timeline
Avertto Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | Cancelled | Generating Revenue | ||||
| 4. Accelerator/Incubator | 05-Sep-2024 | Completed | Generating Revenue | |||
| 3. Seed Round | Completed | Generating Revenue | ||||
| 2. Grant | 01-Sep-2023 | $1.98M | Completed | Generating Revenue | ||
| 1. Grant | 01-Jan-2023 | $100K | Completed | Generating Revenue |
Avertto Comparisons
Industry
Financing
Details
Avertto Competitors (2)
One of Avertto’s 2 competitors is FloPatch, a Venture Capital-Backed company based in Sudbury, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| FloPatch | Venture Capital-Backed | Sudbury, Canada | ||||
| Neuralert | Venture Capital-Backed | Philadelphia, PA |
Avertto Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Avertto Patents
Avertto Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026176426-A1 | System and method for hemodynamic anomaly detection for diagnosis and treatment | Pending | 21-Feb-2025 | ||
| WO-2025177268-A1 | System and method for stroke identification and treatment | Pending | 20-Feb-2024 | ||
| EP-4712845-A1 | Stroke detection | Pending | 14-May-2023 | ||
| US-20260283489-A1 | Stroke detection | Pending | 14-May-2023 | ||
| WO-2024236558-A1 | Stroke detection | Inactive | 14-May-2023 | A61B8/0808 |
Avertto Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Avertto Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Peachscore + Gust Accelerator Program | Accelerator/Incubator | |||
| Innovation Authority | Government | |||
| Hebrew University of Jerusalem Endowment | Limited Partner |
Avertto FAQs
-
When was Avertto founded?
Avertto was founded in 2019.
-
Where is Avertto headquartered?
Avertto is headquartered in Aderet, Israel.
-
What is the size of Avertto?
Avertto has 11 total employees.
-
What industry is Avertto in?
Avertto’s primary industry is Monitoring Equipment.
-
Is Avertto a private or public company?
Avertto is a Private company.
-
What is Avertto’s current revenue?
The current revenue for Avertto is .
-
How much funding has Avertto raised over time?
Avertto has raised $2M.
-
Who are Avertto’s investors?
Peachscore + Gust Accelerator Program, Innovation Authority, and Hebrew University of Jerusalem Endowment have invested in Avertto.
-
Who are Avertto’s competitors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
